Outcomes for liver transplant candidates listed with low model for end-stage liver disease score

被引:36
|
作者
Kwong, Allison J. [1 ]
Lai, Jennifer C. [3 ]
Dodge, Jennifer L. [2 ]
Roberts, John P. [2 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA
关键词
HIGH-RISK; MORTALITY; CIRRHOSIS; DEATH; MELD; PREDICTION; ALLOCATION; ASCITES;
D O I
10.1002/lt.24307
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The Model for End-Stage Liver Disease (MELD) score, which estimates mortality within 90 days, determines priority for liver transplantation (LT). However, longer-term outcomes on the wait list for patients who are initially listed with low MELD scores are not well characterized. All adults listed for primary LT at a single, high-volume center from 2005 to 2012 with an initial laboratory MELD score of 22 or lower were evaluated. Excluded were those patients listed with MELD exception points who underwent living donor liver transplantation (LDLT) or transplantation at another center, or who were removed from the wait list for nonmedical reasons. Outcomes and causes of death were identified by United Network for Organ Sharing, the National Death Index, and an electronic medical record review. Multivariate competing risk analysis evaluated predictors of death compared to deceased donor liver transplantation (DDLT); 893 patients were listed from 2005 to 2012. By the end of follow-up, 27% had undergone DDLT, and 31% were removed from the wait list for death or clinical deterioration. In a competing risks assessment, only MELD score of 6-9, older age, lower serum albumin, lower body mass index, and diabetes conferred an increased risk of wait-list dropout compared to DDLT. Listing for simultaneous liver-kidney transplantation was protective against wait-list dropout. Of the patients included, 275 patients died or were delisted for being too sick; 87% of the identifiable causes of death were directly related to end-stage liver disease or hepatocellular carcinoma. In conclusion, patients with low listing MELD scores remain at a significant risk for death due to liver-related causes and may benefit from early access to transplantation, such as LDLT or acceptance of high-risk donor livers. Predictors of death compared to transplantation may allow for early identification of patients who are at risk for wait-list mortality. Liver Transpl 21:1403-1409, 2015. (c) 2015 AASLD.
引用
收藏
页码:1403 / 1409
页数:7
相关论文
共 50 条
  • [1] Mortality scoring systems for liver transplant recipients: before and after model for end-stage liver disease score
    Chung, Yang-Hoon
    Jung, Jaewoong
    Kim, Sang Hyun
    ANESTHESIA AND PAIN MEDICINE, 2023, 18 (01): : 21 - 28
  • [2] Model for End-Stage Liver Disease and Seven Derivations to Prioritize Liver Transplant Candidates: Which Is the Winner?
    Tohidinezhad, Fariba
    Eslami, Saeid
    Abu-Hanna, Ameen
    Aliakbarian, Mohsen
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2018, 16 (06) : 721 - 729
  • [3] Defining a Liver Transplant Benefit Threshold for the Model for End-Stage Liver Disease-Sodium Score
    Beal, Eliza W.
    Akateh, Clifford
    Tumin, Dmitry
    Bagante, Fabio
    Black, Sylvester M.
    Washburn, Kenneth
    Azouley, Daniel
    Pawlik, Timothy M.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2020, 18 (04) : 491 - 497
  • [4] Is Model for End-Stage Liver Disease score associated with quality of life after liver transplantation?
    Rodrigue, James R.
    Nelson, David R.
    Reed, Alan I.
    Hanto, Douglas W.
    Curry, Michael P.
    PROGRESS IN TRANSPLANTATION, 2011, 21 (03) : 207 - 214
  • [5] Chronic Kidney Disease-Epidemiology Formula and Model for End-Stage Liver Disease Score in the Assessment of Renal Function in Candidates for Liver Transplantation
    Tinti, F.
    Lai, S.
    Umbro, I.
    Mordenti, M.
    Barile, M.
    Corradini, S. Ginanni
    Rossi, M.
    Poli, L.
    Nofroni, I.
    Berloco, P. B.
    Mitterhofer, A. P.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (04) : 1229 - 1232
  • [6] Association of nonstandardized model for end-stage liver disease score exceptions with waitlist mortality in adult liver transplant candidates
    Ahn, Daniel J.
    Kwong, Allison J.
    Wall, Anji E.
    Parker, William F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2025, 25 (02) : 385 - 395
  • [7] Accuracy of the Pediatric End-stage Liver Disease Score in Estimating Pretransplant Mortality Among Pediatric Liver Transplant Candidates
    Chang, Chung-Chou H.
    Bryce, Cindy L.
    Shneider, Benjamin L.
    Yabes, Jonathan G.
    Ren, Yi
    Zenarosa, Gabriel L.
    Tomko, Heather
    Donnell, Drew M.
    Squires, Robert H.
    Roberts, Mark S.
    JAMA PEDIATRICS, 2018, 172 (11) : 1070 - 1077
  • [8] Outcomes After Liver Transplantation in Patients Achieving a Model for End-Stage Liver Disease Score of 40 or Higher
    Alexopoulos, Sophoclis
    Matsuoka, Lea
    Cho, Yong
    Thomas, Elizabeth
    Sheikh, Mohd
    Stapfer, Maria
    Dhanireddy, Kiran
    Sher, Linda
    Selby, Rick
    Genyk, Yuri
    TRANSPLANTATION, 2013, 95 (03) : 507 - 512
  • [9] Survival Before and After Model for End-stage Liver Disease Score Introduction on the Brazilian Liver Transplant Waiting List
    Castro, R. S.
    Deisanti, D.
    Seva-Pereira, T.
    Almeida, J. R. S.
    Yamanaka, A.
    Boin, I. F. S. F.
    Soares, E. C.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (02) : 412 - 416
  • [10] The model for end-stage liver disease predicts outcomes in patients undergoing cholecystectomy
    Dolejs, Scott C.
    Beane, Joal D.
    Kays, Joshua K.
    Ceppa, Eugene P.
    Zarzaur, Ben L.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2017, 31 (12): : 5192 - 5200